|
Re: Report Of Exempt Distribution.
|
7
|
Zenith Epigenetics
|
Apr 16, 2024 07:13PM
|
|
Re: Report of exempt distribution
|
4
|
Resverlogix Corp.
|
Jul 01, 2020 06:54PM
|
|
Re: Remembering last year's buyout rumours....
|
1
|
Resverlogix Corp.
|
Sep 19, 2016 07:03AM
|
|
Re: Regarding mice and Covid
|
3
|
Resverlogix Corp.
|
Nov 30, 2021 05:45PM
|
|
Re: Recent Funding - Zenith CC
|
4
|
Zenith Epigenetics
|
Oct 22, 2022 10:15AM
|
|
Re: Recent Funding - Zenith CC
|
|
Zenith Epigenetics
|
Oct 23, 2022 08:30AM
|
|
Re: Recent Funding - Zenith CC
|
3
|
Zenith Epigenetics
|
Oct 23, 2022 11:51AM
|
|
Re: Received a reply too...
|
4
|
Resverlogix Corp.
|
Sep 12, 2017 12:17PM
|
|
Re: Rebuys start at $2.28
|
5
|
Resverlogix Corp.
|
Aug 09, 2018 04:51PM
|
|
Re: Reading The Tea Leaves
|
1
|
Resverlogix Corp.
|
May 31, 2017 11:02AM
|
|
Re: Reading (parsing, fantasizing) the tea leaves
|
4
|
Resverlogix Corp.
|
Feb 01, 2021 10:28AM
|
|
Re: Reaching 250 MACE
|
4
|
Resverlogix Corp.
|
Apr 23, 2019 11:10AM
|
|
Re: RBC unregistered to registered account
|
2
|
Zenith Epigenetics
|
Mar 29, 2019 07:14AM
|
|
Re: Rationale and Design of Apabetalone BETonMACE Trial
|
2
|
Resverlogix Corp.
|
Dec 04, 2018 07:14AM
|
|
Re: Questions for Q1 webcast
|
4
|
Resverlogix Corp.
|
Mar 05, 2016 09:08PM
|
|
Re: Question for the experts
|
3
|
Zenith Epigenetics
|
Oct 08, 2024 01:07PM
|
|
Re: Qatar Research overview of apabetalone
|
6
|
Resverlogix Corp.
|
Apr 24, 2024 12:36PM
|
|
Re: Q4 2017 Events
|
3
|
Resverlogix Corp.
|
Oct 21, 2017 11:55AM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
1
|
Resverlogix Corp.
|
May 14, 2022 08:22PM
|
|
Re: proxy vote
|
4
|
Resverlogix Corp.
|
Sep 28, 2019 03:47PM
|
